Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427724 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser
A Early Phase 1 study of Lentigo, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT02427724: Active Early Phase 1 study of Lentigo, sponsored by Northwestern University.
NCT02427724 is a Early Phase 1 study of Lentigo that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 48 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02427724, a Early Phase 1 study of Lentigo, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will conduct a split-face and -body randomized control trial to compare lidocaine 2.5%/prilocaine 2.5% topical anesthetic (LPTA), lidocaine 7%/tetracaine 7% topical anesthetic (LTTA), and placebo vechicle (PV) on patients' pain perceptions with Q-switched 532nm laser for the treatment of lentigines and/or photorejuvenation.Subjects will fill out a pain score on a visual analog scale (VAS) with 0 being no pain and 10 being most pain after each treatment area is completed.
Primary Outcome
Subjects will fill out a visual analog score (VAS) pain rating after treatment with 0 being no pain and 10 being worst pain
Conditions Studied
Interventions
- DRUG lidocaine 2.5%/prilocaine 2.5% topical anesthetic
- DRUG lidocaine 7%/tetracaine 7% topical anesthetic
- DRUG placebo vehicle
- DEVICE Q-switched 532nm Laser
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-04 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
What the registry record for NCT02427724 still lists
NCT02427724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 1 condition, with Lentigo appearing as the primary indexed condition, and to 4 interventions - of which lidocaine 2.5%/prilocaine 2.5% topical anesthetic is the first listed.
NCT02427724 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02427724 about?
NCT02427724 is a clinical study titled "The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser". This study will conduct a split-face and -body randomized control trial to compare lidocaine 2.5%/prilocaine 2.5% topical anesthetic (LPTA), lidocaine 7%/tetracaine 7% topical anesthetic (LTTA), and placebo vechicle (PV) on patients' pain perceptions with Q-switched 532nm laser for the treatment of ...
What is the current status of trial NCT02427724?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2015-04. Estimated completion is 2025-12.
What conditions does trial NCT02427724 study?
This clinical trial studies the following conditions: Lentigo.
What interventions are being tested in trial NCT02427724?
The interventions under investigation include: lidocaine 2.5%/prilocaine 2.5% topical anesthetic (DRUG), lidocaine 7%/tetracaine 7% topical anesthetic (DRUG), placebo vehicle (DRUG), Q-switched 532nm Laser (DEVICE).
Who is sponsoring clinical trial NCT02427724?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02427724 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02427724's enrollment target sits among peer trials
48 541st of 2000 higher than 1,439 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia